Table 1.

Comparison of Tumor Size Before and After Neoadjuvant Therapy as Determined by Molecular Breast Imaging, Clinical Examination, Mammography, Ultrasound, and Magnetic Resonance Imaging, and at Pathology

Type of Examination	No. of Breast Cancers	Tumor Size, cma
		Pre-NT	Post-NT	At Pathology
MBI	18	5.9 (2.6)	1.8 (2.4)	1.7 (3.0)
CE	16	5.2 (3.7)	1.7 (2.4)	1.7 (3.2)
MMG	8	5.0 (3.3)	0.6 (1.4)	0.4 (0.5)
US	7	3.4 (1.2)	1.2 (1.0)	0.3 (0.4)
MRI	5	6.5 (4.5)	3.7 (3.5)	3.7 (4.7)

Abbreviations: CE, clinical examination; MBI, molecular breast imaging; MMG, mammography; MRI, magnetic resonance imaging; Post-NT, post-neoadjuvant therapy; Pre-NT, pre-neoadjuvant therapy; US, ultrasound.

^aValues are mean (SD).